Market

KWALITY PHARMACEUTICALS LTD.

  • NSE Code-
  • BSE Code539997
  • ISININE552U01010
  • IndustryPharmaceuticals


Company Information

Management

Ms. Gurpreet Kaur

Co. Secretary & Compl. Officer

Incorporation Year

04/05/1983

Registered Address


Amritsar, Punjab - 143601
Tel: 0183-2774321, 2774322, 2774323
Fax: 0183-2774477

Registrar Office

Bigshare Services Pvt. Ltd.
S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Ma
Mumbai,400093,Maharashtra
Tel: 022-62638200
Fax: 62638261

Corporate News

Kwality Pharma. Q3 net profit jumps 87.47% at Rs 16.0...

12-Feb-2026|12:50PM

The company reported standalone net profit of Rs 16.01 crore for the quarte

Kwality Pharma. - Investor Presentation Of Financial ...

12-Feb-2026|12:14PM

Investor Presentation of Financial Results

Kwality Pharma. - Approval Of Unaudited Financial Res...

12-Feb-2026|12:08PM

Approval of Unaudited Financial Results for the quarter and nine months end

Kwality Pharma. - Board Meeting Outcome for Approval ...

12-Feb-2026|11:57AM

Approval of Unaudited Financial Results for the Quarter and Nine Months End

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug70.94201.15
Aarti Drug375.153,423.99
Aarti Pharma710.856,444.41
Abbott India26,660.0056,650.64
Accent Micro326.80783.96

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
Motilal Oswal..0.010.04
Bandhan BSE H..0.010.04

Board Meetings

DatePurpose
12/02/2026Quarterly Results
13/11/2025Quarterly Results
11/08/2025Quarterly Results
19/05/2025Audited Results
31/01/2025Quarterly Results
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.